Market Tracker

09/28 5:48pm ET

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

125.76
Delayed Data
As of 3:59pm ET
 -0.13 / -0.10%
Today’s Change
108.50
Today|||52-Week Range
160.00
-10.53%
Year-to-Date
Jazz Pharma Closes Enrollment in OSA Drug Phase III Trial
10:41am / Zacks.com - Paid Partner Content
The Cheapest Stocks in Biotech
Sep 23 / MotleyFool.com - Paid Partner Content
3 Top Biotech Stocks to Buy on Sale
Sep 26 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close125.89
Today’s open126.56
Day’s range124.44 - 126.65
Volume340,511
Average volume (3 months)749,963
Market cap$7.6B
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+462.37%
Earnings growth (this year)+6.61%
Earnings growth (next 5 years)+15.76%
Revenue growth (last year)+12.95%
P/E ratio22.1
Price/Sales6.69
Price/Book4.83

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+1.24+1.74%
ALKSAlkermes Plc-0.98-1.97%
SGENSeattle Genetics Inc-1.24-2.19%
RDYDr.Reddy's Laborator...+0.06+0.13%
Data as of 4:14pm ET, 09/28/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$2.61
Annual revenue (last year)$1.3B
Annual profit (last year)$329.5M
Net profit margin24.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts